Close
Nordic 9Nordic 9

Arix Bioscience plc (investor - Venture Capital)

United Kingdom arixbioscience.com
See something wrong or missing? Let us know
Offices:London

Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.

Average round investment:35.4M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: France Depixus
Mostly invests in: France France (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Arix Bioscience plc

Name Criteria
France Malakoff Humanis
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Didier Rousseau
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Principia SGR
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Merck Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Belgium V-Bio Ventures
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Lansdowne Partners
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Belgium SFPI-FPIM
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Japan Takeda Pharmaceutical Company Limited
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Israel Pontifax Venture Capital
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Switzerland Pureos Bioventures
71%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Top